enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of investigational sleep drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

3. Somnifacient - Wikipedia

   en.wikipedia.org/wiki/Somnifacient

   Somnifacient (from Latin somnus, sleep [1]), also known as sedatives or sleeping pills, is a class of medications that induces sleep. It is mainly used for treatment of insomnia. Examples of somnifacients include benzodiazepines, barbiturates and antihistamines. Around 2-6% of adults with insomnia use somnifacients to aid sleep. [2]

4. List of withdrawn drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_withdrawn_drugs

   Drug name Withdrawn Country Remarks Amphetamine Mix (Adderall XR) 2005 Canada Withdrawn over reports of increased risk of stroke, reinstated after increased risk not found. [1] Alatrofloxacin: 2006 Worldwide Serious hepatotoxicity leading to liver transplant or death. [2] Alclofenac: 1979 UK Vasculitis [3] Alpidem (Ananxyl) 1995 Worldwide

5. List of antipsychotics - Wikipedia

   en.wikipedia.org/wiki/List_of_antipsychotics

   Main page; Contents; Current events; Random article; About Wikipedia; Contact us

6. Estazolam - Wikipedia

   en.wikipedia.org/wiki/Estazolam

   Estazolam, sold under the brand name Prosom among others, is a tranquilizer medication of the triazolobenzodiazepine (TBZD) class, which are benzodiazepines (BZDs) fused with a triazole ring. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Estazolam is an intermediate-acting oral benzodiazepine.

7. Orexin antagonist - Wikipedia

   en.wikipedia.org/wiki/Orexin_antagonist

   Filorexant was studied for but was not found to be effective in the treatment of diabetic neuropathy, migraine, and major depressive disorder in phase 2 clinical trials. [35] [36] [37] Seltorexant is under development for treatment of major depressive disorder however and is in phase 3 trials for this indication. [38]